23 May 2013
Keywords: UK, Value-based pricing, Patient drug access, Stockholm Network, Myeloma UK
Article | 18 March 2011
The proposed reforms to the way that medicines are priced within the UK’s National Health Service are unlikely ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 March 2011
17 March 2011
22 May 2013
© 2013 thepharmaletter.com